You are here
Articles
Posted on Friday, December 22, 2017 - 5:25pm
Molecular Responses after Switching from a Standard-Dose Twice-Daily Nilotinib Regimen to a Reduced-Dose Once-Daily Schedule in Patients with Chronic Myeloid Leukemia: A Real Life Observational Study (NILO-RED)
Posted on Thursday, November 2, 2017 - 4:20pm
Over the last two decades, targeted therapies like imatinib (Gleevec®)and ...
Posted on Thursday, September 21, 2017 - 1:13pm
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.
Posted on Saturday, September 9, 2017 - 2:02pm
Tessa Holyoake was a giant in the world of CML and her loss to the research community, patients and her fellow specialist clinicians is and will continue to be keenly felt.
Posted on Saturday, July 29, 2017 - 5:26pm
European Stop TKI Study (EURO-SKI), show that stopping TKI therapy is feasible and that about half of patients remain free from relapse after 2 years of follow-up.
Posted on Saturday, July 29, 2017 - 12:26pm
Introduction:
Posted on Thursday, July 20, 2017 - 5:39pm
Cancer cells are escape artists by nature. They can dodge drugs designed to cripple them due to one of their defining characteristics: their genetic makeup changes rapidly.
Posted on Saturday, July 8, 2017 - 5:15pm
A Hochhaus1, T Masszi2, F J Giles3, J P Radich4, D M Ross5, M T Gómez Casares6, A Hellmann7, J Stentoft8, E Conneally9, V García-Gutiérrez10, N Gattermann11, W Wiktor-Jedrzejczak12, P D le Coutre13, B Martino14, S...
Posted on Saturday, June 10, 2017 - 5:16pm
Imatinib Discontinuation In Chronic Myeloid Leukemia: The IMMUNOSTIM Study
Posted on Saturday, May 13, 2017 - 3:54pm
Burwick, Richard M. MD, MPH; Kuo, Kelly MD; Brewer, Diana PA; Druker, Brian J. MD
Posted on Sunday, April 2, 2017 - 3:34pm
In patients with chronic myeloid leukemia (CML), longer treatment duration is associated with an increase in the odds ratio for preserving a major molecular response (MMR) six months after discontinuing tyrosine kinase...
Posted on Sunday, January 8, 2017 - 1:51pm
December 05, 2016 | ASH 2016, Chronic Myeloid Leukemia
Posted on Sunday, January 8, 2017 - 1:43pm
News, January 04, 2017
Posted on Tuesday, December 13, 2016 - 5:25pm
Leukemia, November 2016; advance online publication
Posted on Thursday, December 8, 2016 - 2:35pm
Outcomes of the EURO-SKI Trial and the British DESTINY Study reported at the 58th Annual Meeting of the American Society of Haematology, December 3 – 6.
- ‹ previous
- 6 of 33
- next ›